🔔Stock Alerts via Telegram — Free for All Users

Stock Comparison

UNH vs VRAX

UnitedHealth Group Inc vs Virax Biolabs Group Ltd

The Verdict

VRAX takes this one.

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed
Winner
VRAX

Virax Biolabs Group Ltd

1.5

out of 10

Distressed

Head-to-Head

$276.2B

Market Cap

$772,779.3
22.9

P/E Ratio

N/A
2.7%

Profit Margin

-188748.8%
12.5%

Return on Equity

-102.5%
0.0

Debt-to-Equity

0.1
Moderate-High

Overall Risk

Aggressive
0.3

DVR Score

1.5

The Deep Dive

UNH0.3/10

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...

Full UNH Analysis
VRAX1.5/10

Score Change Explanation: The previous analysis was based on a reported market capitalization of $0.00B, implying zero operational viability. New market intelligence indicates a calculable market cap of approximately $3.98M (19.9M shares @ $0.20), a recent capital injection of $5M from warrant exercises, and operational progress with ISO certifications. These material changes contradict the previo...

Full VRAX Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.